loadpatents
name:-0.062794923782349
name:-0.15102005004883
name:-0.019510984420776
Blizzard; Charles D. Patent Filings

Blizzard; Charles D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blizzard; Charles D..The latest application filed is for "pulmonary pharmaceutical formulations".

Company Profile
7.14.30
  • Blizzard; Charles D. - Westwood MA
  • Blizzard; Charles D. - Nashua NH
  • Blizzard; Charles D. - Roxbury MA
  • Blizzard; Charles D. - West Roxbury MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pulmonary Pharmaceutical Formulations
App 20220296612 - Blizzard; Charles D. ;   et al.
2022-09-22
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
App 20220296559 - Ward; Kevin L. ;   et al.
2022-09-22
Ocular implant containing a tyrosine kinase inhibitor
Grant 11,439,592 - Blizzard , et al. September 13, 2
2022-09-13
Shape changing drug delivery devices and methods
Grant 11,413,250 - Jarrett , et al. August 16, 2
2022-08-16
Compositions And Methods For Treating Ocular Diseases
App 20220218643 - Blizzard; Charles D. ;   et al.
2022-07-14
Sustained Release Biodegradable Intracanalicular Inserts Comprising A Hydrogel And Cyclosporine
App 20220202706 - Blizzard; Charles D. ;   et al.
2022-06-30
Drug delivery from hydrogels
Grant 11,369,591 - Jarrett , et al. June 28, 2
2022-06-28
Ocular Insert Containing A Glucocorticoid
App 20220183969 - Blizzard; Charles D. ;   et al.
2022-06-16
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
Grant 11,331,267 - Blizzard , et al. May 17, 2
2022-05-17
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
Grant 11,291,627 - Blizzard , et al. April 5, 2
2022-04-05
Sustained Release Biodegradable Intracanalicular Inserts Comprising A Hydrogel And Cyclosporine
App 20220087932 - Blizzard; Charles D. ;   et al.
2022-03-24
Sustained Release Biodegradable Intracanalicular Inserts Comprising A Hydrogel And Cyclosporine
App 20220087931 - Blizzard; Charles D. ;   et al.
2022-03-24
Ocular Implant Containing A Tyrosine Kinase Inhibitor
App 20220079876 - Blizzard; Charles D. ;   et al.
2022-03-17
Ocular Implant Containing A Tyrosine Kinase Inhibitor
App 20210308043 - Blizzard; Charles D. ;   et al.
2021-10-07
Compositions and Methods for Treating Ocular Diseases
App 20210251893 - Blizzard; Charles D. ;   et al.
2021-08-19
Shape Changing Drug Delivery Devices And Methods
App 20210128478 - Jarrett; Peter ;   et al.
2021-05-06
Hydrogel Implants For Lowering Intraocular Pressure
App 20200337990 - Goldstein; Michael ;   et al.
2020-10-29
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants
App 20200337989 - Jarrett; Peter ;   et al.
2020-10-29
Shape changing drug delivery devices and methods
Grant 10,786,462 - Jarrett , et al. September 29, 2
2020-09-29
Shape Changing Drug Delivery Devices And Methods
App 20200030241 - Jarrett; Peter ;   et al.
2020-01-30
Shape changing drug delivery devices and methods
Grant 10,420,724 - Jarrett , et al. Sept
2019-09-24
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
App 20190022053 - Ward; Kevin L. ;   et al.
2019-01-24
Intracameral Drug Delivery Depots
App 20180085307 - Sawhney; Amarpreet S. ;   et al.
2018-03-29
Shape Changing Drug Delivery Devices And Methods
App 20170143636 - Jarrett; Peter ;   et al.
2017-05-25
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
App 20170007571 - Ward; Kevin L. ;   et al.
2017-01-12
Drug Delivery From Hydrogels
App 20160331738 - Jarrett; Peter ;   et al.
2016-11-17
Pulmonary Pharmaceutical Formulations
App 20160151393 - Blizzard; Charles D. ;   et al.
2016-06-02
Pulmonary Pharmaceutical Formulations
App 20140148424 - Blizzard; Charles D. ;   et al.
2014-05-29
Pulmonary pharmaceutical formulations
Grant 8,614,255 - Blizzard , et al. December 24, 2
2013-12-24
Drug delivery through hydrogel plugs
Grant 8,563,027 - Jarrett , et al. October 22, 2
2013-10-22
Drug Delivery Through Hydrogel Plugs
App 20130172268 - Jarrett; Peter ;   et al.
2013-07-04
Complex Of Trospium And Pharmaceutical Compositions Thereof
App 20100272811 - Scher; David S. ;   et al.
2010-10-28
Pulmonary Pharmaceutical Formulations
App 20090105201 - Blizzard; Charles D. ;   et al.
2009-04-23
Method and apparatus for producing dry particles
App 20080108554 - Jackson; Blair C. ;   et al.
2008-05-08
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
App 20080063722 - Ward; Kevin L. ;   et al.
2008-03-13
Method for administration of growth hormone via pulmonary delivery
App 20050163725 - Blizzard, Charles D. ;   et al.
2005-07-28
hGH (human growth hormone) formulations for pulmonary administration
App 20040009231 - Jackson, Blair ;   et al.
2004-01-15
Method and apparatus for producing dry particles
App 20030222364 - Jackson, Blair C. ;   et al.
2003-12-04
Sustained release microspheres
App 20030059474 - Scott, Terrence L. ;   et al.
2003-03-27
Sustained release microspheres
Grant 6,458,387 - Scott , et al. October 1, 2
2002-10-01
Macromolecular microparticles and methods of production and use
Grant 6,268,053 - Woiszwillo , et al. July 31, 2
2001-07-31
Macromolecular microparticles and methods of production and use
Grant 6,090,925 - Woiszwillo , et al. July 18, 2
2000-07-18
Macromolecular microparticles and methods of production and use
Grant 5,981,719 - Woiszwillo , et al. November 9, 1
1999-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed